BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18079253)

  • 21. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
    Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Shimokata K; Inoue H; Nukiwa T; Miyaoka E;
    J Thorac Oncol; 2008 Jan; 3(1):46-52. PubMed ID: 18166840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent clinical advances in lung cancer management.
    Johnson DH; Schiller JH; Bunn PA
    J Clin Oncol; 2014 Apr; 32(10):973-82. PubMed ID: 24567433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal therapy for elderly patients with early stage non-small cell lung cancer.
    Bunn PA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):201-2. PubMed ID: 20093653
    [No Abstract]   [Full Text] [Related]  

  • 24. [Histoligic type of the tumor as an independent factor for survival in non-small cell lung cancer].
    Uchikov A; Staribratova D; Prisadov G; Uchikova E; Dimitrov I; Batashki A
    Khirurgiia (Sofiia); 2009; (4-5):24-6. PubMed ID: 20506801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endobronchial ultrasonography (EBUS)--its role in staging of non-small cell lung cancer and who should do it?
    Andrade RS; Odell DD; D'Cunha J; Maddaus MA
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S9-13. PubMed ID: 22898528
    [No Abstract]   [Full Text] [Related]  

  • 26. Lung Cancer OncoGuia.
    ; Manchon Walsh P; Manchon P; Borràs JM; Ferro T; Espinàs JA
    Clin Transl Oncol; 2009 Dec; 11(12):805-24. PubMed ID: 20045787
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspects of diagnosis and staging of non-small-cell lung cancer.
    Larcos G
    Med J Aust; 1998 Mar; 168(5):256. PubMed ID: 9539911
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent developments in the diagnosis and treatment of lung cancer.
    Gilligan D
    Int J Clin Pract; 1998; 52(5):330-4. PubMed ID: 9796565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor-associated prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M
    Pneumologie; 1997 Jul; 51(7):669-77. PubMed ID: 9333800
    [No Abstract]   [Full Text] [Related]  

  • 31. Bibliography. Current world literature. Lung and mediastinum.
    Curr Opin Oncol; 2004 Mar; 16(2):184-97. PubMed ID: 15083801
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bronchial carcinoma. Epidemiology, diagnosis and therapy].
    Macha HN
    Internist (Berl); 2003 Jun; 44 Suppl 1():S28-34. PubMed ID: 14567086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [P27 expression and survival in NSCLC].
    Hirabayashi H
    Nihon Rinsho; 2002 May; 60 Suppl 5():263-6. PubMed ID: 12101669
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-small cell lung cancer (NSCLC)].
    Yoshimori K
    Nihon Rinsho; 2002 May; 60 Suppl 5():294-7. PubMed ID: 12101676
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan.
    Tsai CH; Kung PT; Kuo WY; Tsai WC
    BMJ Open; 2020 Apr; 10(4):e034351. PubMed ID: 32327476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung Cancer.
    Lareau S; Slatore C; Smyth R
    Am J Respir Crit Care Med; 2021 Dec; 204(12):P21-P22. PubMed ID: 34908517
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-small cell lung cancer: early stages.
    Bria E; Ceribelli A; Trovò MG; Gelibter A; Gigante M; Calabrò E; Cuppone F; Cognetti F; Terzoli E; Pastorino U
    Ann Oncol; 2006 Mar; 17 Suppl 2():ii17-21. PubMed ID: 16608973
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancer.
    Vos CG; Dahele M; Dickhoff C; Senan S; Thunnissen E; Hartemink KJ
    Acta Oncol; 2013 Apr; 52(3):676-8. PubMed ID: 23098694
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation and treatment of patients with non-small cell lung cancer.
    Carr LL; Finigan JH; Kern JA
    Med Clin North Am; 2011 Nov; 95(6):1041-54. PubMed ID: 22032426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.